The Astellas Way Blog

Archives: 2019 / 2018 / 2017 / 2016

 

Nov 8, 2019
By Effie Tozzo, PhD, Senior Vice President, Translational Sciences, Mitobridge, An Astellas Company
Sep 3, 2019
By Mark Reisenauer, Senior Vice President, Oncology Business Unit
Jun 26, 2019
By Eloiza Domingo-Snyder, Executive Director of Diversity & Inclusion
Apr 10, 2019
By Yoshitsugu Shitaka, President, Astellas Institute for Regenerative Medicine
Mar 31, 2019
By Linda Friedman, EVP, General Counsel
Mar 7, 2019
An Interview with Astellas Americas President
Feb 4, 2019
By Pete Sandor, Vice President, Global Oncology
Jan 24, 2019
By Percival Barretto-Ko, President Astellas Americas
Nov 29, 2018
By Percival Barretto-Ko, President, Astellas Americas
Aug 17, 2018
By Doug Noland, Executive Director, Patient Experience
Jun 29, 2018
By Mark Reisenauer, Senior Vice President, Oncology
Feb 14, 2018
By Bernhardt G. Zeiher, MD, FACP, FCCP, President, Development; Incoming Chief Medical Officer
Dec 18, 2017
By Jim Robinson, President, Astellas Americas
Dec 1, 2017
By Jim Robinson, President, Astellas Americas
Oct 10, 2017
By Jim Robinson, President, Astellas Americas
Aug 30, 2017
By Jim Robinson, President, Astellas Americas
Jul 13, 2017
By Jim Robinson, President, Astellas Americas
May 31, 2017
By Mark Reisenauer, Senior Vice President, Oncology
Apr 26, 2017
By Jim Robinson The Astellas Way
Mar 29, 2017
By Jeffrey (Jeff) Winton, Senior Vice President, Corporate Affairs
Mar 22, 2017
By Jim Robinson, President, Astellas Americas
Feb 9, 2017
By Jim Robinson, President, Astellas Americas